Clinical Trials Logo

Clinical Trial Summary

Hypotonia, particularly of the masticatory and oropharyngeal muscles, is one of the main characteristics of Down syndrome, resulting in impaired speech, chewing and swallowing. Moreover, the complete or partial obstruction of the airways during sleep may occur due to hypotonia of the tongue, leading to snoring and sleep disorders, such as obstructive apnea and sleep bruxism. Objectives: Analyze salivary levels of dopamine and cortisol and muscle activity before and after treatment with low-level laser therapy administered to acupoints in children with Down syndrome. Methods: A randomized, controlled, clinical trial will be conducted. Individuals four to 17 years of age with a diagnosis of Down syndrome and possible sleep bruxism will be screened at the Integrated Health Clinic of Nove de Julho University. We will evaluate orofacial dysfunction (NOT-S questionnaire), facial sensitivity, activity of the masticatory and trapezius muscles (electromyography), head posture as well as salivary cortisol and dopamine. After the evaluations, the participants will be randomized into two groups: Grupo 1 - treatment with low-level laser therapy at a wavelength of 808 nm; Group 2 - sham treatment (simulated laser therapy). Treatment will be conducted twice per week for a total of 12 sessions. The data will be tabulated and treated using GraphPad Prism version 7.0. The Kolmogorov-Smirnov test will be used to determine the normality of the data. Variables that fit the Gaussian curve will be expressed as mean and standard deviation. The t-test will be used for comparisons between the groups, with the significance level set to 5% (p <0.05).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04211870
Study type Interventional
Source University of Nove de Julho
Contact
Status Not yet recruiting
Phase Phase 1/Phase 2
Start date March 20, 2020
Completion date December 20, 2020

See also
  Status Clinical Trial Phase
Terminated NCT03522207 - Accuracy and Efficacy of Trazodone (Desyrel) on Sleep Quality and Pain Management of TMD Patient Phase 4
Not yet recruiting NCT05301452 - Evaluation of Intravascular Irradiation of Blood in Children With Sleep Bruxism Phase 2
Completed NCT02340663 - Nocturnal Mouth Guards, SOVA vs. Standard Acrylic Orthotic; Phase IV N/A
Recruiting NCT06153810 - Efficacy of AesyBite Active in Reducing Sleep Bruxism Activity N/A
Completed NCT03325920 - Validation of a Diagnostic Method for Quantification of Sleep Bruxism N/A
Not yet recruiting NCT05784454 - Prevalance of Sleep Bruxism Among a Group of Egyptian Children
Completed NCT02410681 - Sleep Bruxism and (Peri-)Implant Complications
Recruiting NCT01336439 - Effects of Botulinum Toxin Type A(Meditoxin®) on Sleep Bruxism Phase 4
Completed NCT01255878 - Comparative Evaluation of Gabapentine and Occlusal Splint in the Management of Sleep Bruxism N/A
Not yet recruiting NCT02757261 - Evaluation of Muscle Activity, Bite Force and Salivary Cortisol in Children With Bruxism Phase 0
Enrolling by invitation NCT04937036 - Impact of Bruxism Related Arousals on Cardiovascular Risk in Co-morbid Insomnia and Sleep Apnea
Completed NCT02882880 - Treatment Sleep Bruxism With the Luco Hybrid OSA Appliance N/A
Withdrawn NCT04078074 - Occlusal Stabilization Splints and Sleep Disordered Breathing N/A
Completed NCT01178229 - Physiotherapy on the Airway of Bruxist Children Phase 1/Phase 2
Completed NCT03766477 - Aspects Associated With Sleep Quality
Recruiting NCT06343194 - Changes in Electromyographic Activity in Aligner Treatment of Adult Patients With and Without Nocturnal Bruxism N/A
Completed NCT03039985 - All-ceramic Crowns in Patients With Sleep Bruxism N/A
Enrolling by invitation NCT04214561 - Relationship Between Selected Parameters and Bruxism
Recruiting NCT06214637 - Effectiveness of Melissa Officinalis for the Treatment of Probable Sleep Bruxism in Children and Adolescents Phase 1
Enrolling by invitation NCT03083405 - Selected Disorders and Sleep Bruxism